|
⚲
|
| Smith Breeden Credit Partners L P | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001364984 |
| Sale | 2005-12-15 ($81.8 M Sold) |
| Fund | |
| Phone | 9199677221 |
| Address | Smith Breeden Associates, Inc Durham, 27517 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Smith Breeden Associates Inc | |
| Daniel Dektar | |
| Jay Gladieux | |
| Michael Giarla | |
| Stanley Kon | |
| Stephen Eason | |
| Dr Eugene Flood | |
| Kent Fleming | |
| Peter Nolan |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Vifor Pharma Ltd.
✚
|
0.0 | |
|
Wuri Ventures II, LP - A1
✚
|
0.0 | |
|
mabl, Inc.
✚
|
0.0 | |
|
Westlake Apts LP
✚
|
0.0 | |
|
1601 Wico Mezz, LP
✚
|
0.0 | |
|
40 North GP III LLC
✚
|
0.0 | |
|
AC Varda II LLC
✚
|
0.0 | |
|
AM 2014 Co CV
✚
|
0.0 | |
|
APO Verb LLC
✚
|
0.0 | |
|
Sepratech TopCo, LLC
✚
|
0.0 |